Exploring the Effects of Aerobic Exercise Combined With BFRT on Patients With COPD
Exploring the Effects of Aerobic Exercise Combined With Blood Flow Restriction Training on Exercise Capacity, Cardiopulmonary Functions, and Quality of Life in Patients With Chronic Obstructive Pulmonary Disease
Investigate the effects of exercise training on the cardiopulmonary function and exercise capacity in COPD patients.
Studieoversikt
Status
Status
Forhold
Forhold
Intervensjon / Behandling
Intervensjon / Behandling
Detaljert beskrivelse
The systemic effects of Chronic Obstructive Pulmonary Disease (COPD) can precipitate a series of complications, including cardiovascular disorders, muscle atrophy, and osteoporosis. These comorbid conditions often result in decreased physical activity and suboptimal physical fitness, compelling patients to lead a sedentary lifestyle to mitigate exercise-induced dyspnea. Addressing the limitations in exercise tolerance remains a critical therapeutic goal in the treatment of COPD. According to research, exercise intolerance is caused by both poor pulmonary function and associated skeletal muscle dysfunction. Blood flow restriction training, a new rehabilitation technique, has shown promise in improving muscular strength at lower exercise intensities and in shorter timeframes, presenting a fresh approach to COPD rehabilitation.
The research aims to investigate the impact of incorporating blood flow restriction training into a holistic aerobic exercise program on exercise capacity and quality of life among patients with COPD. The findings are intended to clarify the potential of this innovative training technique as a supplementary therapeutic strategy in the management of COPD.
Studietype
Studietype
Registrering (Antatt)
Registrering
Fase
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiekontakt
Studiekontakt
- Navn: Kun-Ling Tsai, Ph.D.
- Telefonnummer: 5078 886-6-2353535
- E-post: kunlingtsai@mail.ncku.edu.tw
Studer Kontakt Backup
- Navn: Yu-Ting Huang, M.S.
- Telefonnummer: 5078 886-6-2353535
- E-post: t66061053@pt.ncku.edu.tw
Studiesteder
-
-
Taiwan
-
Tainan, Taiwan, Taiwan, 701
- Rekruttering
- National Cheng Kung University Hostipal
-
Ta kontakt med:
- Kun-Ling Tsai, PhD
- Telefonnummer: 6219 062353535
- E-post: kunlingtsai@mail.ncku.edu.tw
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- COPD classified as levels 2-4.
- Stable condition without worsening in the past three months.
- No participation in any rehabilitation program within the past six months.
- Ability to understand and follow verbal commands and cooperate with an exercise training program.
Exclusion Criteria:
- Unconscious or unable to cooperate with the evaluator.
- Hospitalization due to acute illness within the past three months.
- Severe joint diseases or history of lower limb surgery.
- Severe cardiovascular disease (e.g., presence of a cardiac pacemaker or acute myocardial infarction within the past six months).
- Dependence on oxygen supply.
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Forebygging
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Antall våpen
Våpen og intervensjoner
Deltakergruppe / ArmDeltakergruppe / Arm |
Intervensjon / BehandlingIntervensjon / Behandling |
|---|---|
|
Aktiv komparator: Usual care group
The Usual care group will receive COPD and exercise-related education. |
The participants will be provided by educational program about COPD self-care and home-based exercise approach. |
|
Eksperimentell: Aerobic exercise group-cycling
The aerobic exercise group will receive cycling training intervention 2-3 times per week for 2 months. |
The aerobic exercise intervention will utilize an ergometer. The program will be conducted 2-3 times per week over a 3-month period. |
|
Eksperimentell: BFR group-cycling + BFR
The BFR group will receive cycling training combined with BFR intervention 2-3 times per week for 2 months. |
Blood flow restriction (BFR) intervention will combine aerobic exercise on the ergometer with BFR training. The program will be conducted 2-3 times per week over a 3-month period. |
Hva måler studien?
Primære resultatmål
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Oxygen consumption (VO2)
Tidsramme: Change from baseline (0 week) to follow up (20 weeks)
|
Oxygen consumption examined by cardiopulmonary exercise test |
Change from baseline (0 week) to follow up (20 weeks)
|
|
Functional capacity
Tidsramme: Change from baseline (0 week) to follow up (20 weeks)
|
Functional capacity examined by 6MWT |
Change from baseline (0 week) to follow up (20 weeks)
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Heart Rate Variability
Tidsramme: Change from baseline (0 week) to follow up (20 weeks)
|
Heart Rate Variability examined by autonomic nervous system |
Change from baseline (0 week) to follow up (20 weeks)
|
|
Pulmonary function test
Tidsramme: Change from baseline (0 week) to follow up (20 weeks)
|
Pulmonary function test examined by spirometer. Spirometry is a physiological test that measures the ability to inhale and exhale air over time. The main spirometry results are forced vital capacity (FVC), forced expiratory volume in the first second (FEV1), and the FEV1/FVC ratio. |
Change from baseline (0 week) to follow up (20 weeks)
|
|
Maximum respiratory pressure
Tidsramme: Change from baseline (0 week) to follow up (20 weeks)
|
Maximum respiratory pressure examined by pressure meter |
Change from baseline (0 week) to follow up (20 weeks)
|
|
Quality of life score (COPD-related questionnaire-I)
Tidsramme: Change from baseline (0 week) to follow up (20 weeks)
|
Quality of life score examined by mMRC Questionnaire. |
Change from baseline (0 week) to follow up (20 weeks)
|
|
Quality of life score (COPD-related questionnaire-II)
Tidsramme: Change from baseline (0 week) to follow up (20 weeks)
|
COPD Assessment Test (CAT) questionaire |
Change from baseline (0 week) to follow up (20 weeks)
|
|
Quality of life score (COPD-related questionnaire-III)
Tidsramme: Change from baseline (0 week) to follow up (20 weeks)
|
St George's Respiratory Questionnaire (SGRQ) |
Change from baseline (0 week) to follow up (20 weeks)
|
|
Diaphragm capacity
Tidsramme: Change from baseline (0 week) to follow up (20 weeks)
|
Diaphragm capacity examined by diaphragmatic ultrasound |
Change from baseline (0 week) to follow up (20 weeks)
|
Samarbeidspartnere og etterforskere
Sponsor
Sponsor
Etterforskere
Etterforskere
- Hovedetterforsker: Kun-Ling Tsai, Ph.D., Department of Physical Therapy, National Cheng Kung University
Publikasjoner og nyttige lenker
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Studiestart
Primær fullføring (Antatt)
Primær fullføring
Studiet fullført (Antatt)
Studiet fullført
Datoer for studieregistrering
Først innsendt
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Faktiske)
Først lagt ut
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Sist oppdatering lagt ut
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
Andre studie-ID-numre
- B-ER-113-298
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
IPD-planbeskrivelse
IPD sharing plan will be decided after summarized data being published.
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Studerer et amerikansk FDA-regulert enhetsprodukt
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .